Global Pain Management Therapeutics Market Is Expected To Grow At A CAGR of 4.12% by 2028

According to the report, the global Pain Management Therapeutics market size was valued at approximately USD 70.96 billion in 2021 and is predicted to reach around USD 92.63 billion by the end of 2028, expanding at a CAGR of around 4.1% from 2022 to 2028. The study examines the drivers, constraints, and challenges in the pain management therapeutics market, as well as their impact on demand throughout the forecast period. In addition, the report looks into potential opportunities in the market for pain management therapies.

Pain management is the medicinal aspect of relieving pain which may range from simple to acute or chronic to challenging. The global pain management therapeutics market involves multiple types of pain-relieving techniques including medicines, psychological therapies, physical therapies, support groups, and mind and body techniques. The causes of pain include injury, surgery, or medical conditions like arthritis, cancer, back pain, etc. Pain management devices are used for relieving acute pain occurring because of diseases like musculoskeletal disorders, neurological disorders, and cancer, among others.

COVID-19 hurt the global market owing to multiple regulations laid down by WHO & government regulatory bodies. Disruption in the supply chain as a result of COVID-19 was a leading cause of the dip in the global market growth.

However, the global market is displaying positive signs of steady growth during the projection period.

An increasing number of geriatric patients globally is expected to propel the global pain management therapeutics market during the forecast period. A rise in the number of cancer patients and patients suffering from acute pain disorders along with an increasing number of domestic & international pain reliever medicine producers is expected to assist in the global market growth. Obesity and an unhealthy lifestyle, which are major causes of joint pains, increasing surgical cases globally, and rising awareness about proper pain management are expected to boost the global market growth of pain-relieving devices during the projection period.

The rise in issues about drug exploitation, as well as the expiration of patents on prescription pain medicine pharmaceuticals, are likely to impede the expansion of the pain management therapeutics market. The advent in the pharmaceutical sector and increased research activities have boosted the market reach in emerging countries. However, the global market growth is expected to be slowed by a slew of opioid-related side effects.

The global pain management therapeutics market is bifurcated based on drug class, indication, pain type, and region. Based on drug class, the market is split into anticonvulsants, NSAIDs, anesthetics, anti-migraine drugs, non-narcotics, antidepressant drugs, opioids, and analgesics. By indication, the market is categorized into chronic pain, neuropathic pain, arthritic pain, bone fracture, cancer pain, migraine, fibromyalgia, post-operative pain, acute appendicitis, muscle sprain/strain, and other indications. The pain type segment of the market is divided into acute and chronic.

.North America is anticipated to become the largest global pain management therapeutics market contributor owing to the presence of a large elderly population along with world-class facilities for cancer & other neurological disease treatment and the use of pain management therapeutics in ambulance services.

Asia Pacific is expected to register the highest CAGR during the forecast period because of the presence of multiple pain management drugs and device manufacturers offering reasonably priced and quality products.

The Middle East is expected to contribute significantly to the global market growth because of the rising prevalence of hiring internationally trained physicians as well as the opening of multiple pain relieving facilities during the forecast period.

Key players operating in the global pain management therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., and Johnson & Johnson

Recent Developments

• March 2021, the market has been introduced to "Salonpas," a pain-relieving gel for individuals suffering from arthritis (knee, ankles, hands, etc.). Hisamitsu America is the company that created the topical gel. The results of Hisamitsu America's newest clinical research were recently announced, supporting the argument for topical pain medications as first-line therapy for pain. Furthermore, it is a non-greasy gel that aids in the reduction of inflammation and gives relief from discomfort.

Browse the full “Pain Management Therapeutics Market By Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, And Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, And Other Indications), By Pain Type (Chronic And Acute), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/pain-management-therapeutics-market

Global pain management therapeutics market is segmented as follows:

By Drug Class

• NSAIDS
• Anesthetics
• Anticonvulsant
• Anti-Migraine Drugs
• Antidepressant Drugs
• Opioids
• Non-Narcotics
• Analgesics

By Indication

• Arthritic Pain
• Neuropathic Pain
• Cancer Pain
• Chronic Pain
• Post-Operative Pain
• Migraine
• Fibromyalgia
• Bone Fracture
• Muscle Sprain/Strain
• Acute Appendicitis
• Other

By Pain Type

• Chronic
• Acute

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com